Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10912750 Modulators of Sestrin-GATOR2 interaction and uses thereof

Patent 10912750 was granted and assigned to Navitor Pharmaceuticals on February, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Navitor Pharmaceuticals

Current Assignee

Navitor Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

109127500

Patent Inventor Names

George Vlasuk0

Eddine Saiah0

Date of Patent

February 9, 2021

Patent Application Number

159621230

Date Filed

April 25, 2018

Patent Citations Received

‌

US Patent 11679090 Modulators of Sestrin-GATOR2 interaction and uses thereof

‌

US Patent 11345654 Polymorphic compounds and uses thereof

‌

US Patent 11325924 Modulators of Sestrin-GATOR2 interaction and uses thereof

‌

US Patent 11697633 Polymorphic compounds and uses thereof

Patent Primary Examiner

‌

Shobha Kantamneni

Patent abstract

The present invention provides compounds, compositions thereof, and methods of using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10912750 Modulators of Sestrin-GATOR2 interaction and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API